Trends in the prevalence of type 2 diabetes and prediabetes in a Japanese community, 1988-2012: the Hisayama Study.
75-g oral glucose tolerance test
Community-based research
Prediabetes
Prevalence
Type 2 diabetes
Journal
Diabetology international
ISSN: 2190-1678
Titre abrégé: Diabetol Int
Pays: Japan
ID NLM: 101553224
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
12
07
2018
accepted:
23
10
2018
entrez:
6
7
2019
pubmed:
6
7
2019
medline:
6
7
2019
Statut:
epublish
Résumé
We estimated secular trends in the prevalence of type 2 diabetes (T2DM) and prediabetes, and examined potential explanatory factors for these trends in a Japanese community. 4 cross-sectional examinations were conducted among subjects aged 40-79 years in 1988 ( The age-standardized prevalence of T2DM increased significantly in both sexes from 1988 to 2002, and thereafter it remained stable in men, and decreased nonsignificantly in women from 2002 to 2012. The age-standardized prevalence of prediabetes in men increased significantly between 1988 and 2002, but then decreased significantly. A similar trend was observed in women. The age-specific prevalence of T2DM increased greatly in men aged 60-79 years and women aged 70-79 years from 1988 to 2002, and then plateaued at a high level, while a significant decreasing trend was observed in women aged 40-49 years. The mean values of body mass index (BMI) increased steeply in these elderly subjects from 1988 to 2002, and remained at a high level, whereas those in middle-aged women decreased appreciably over the study period. Our findings suggest that in Japanese, there was no further increase in the prevalence of T2DM or prediabetes in either men or women in the 2000s. Secular change in the BMI level was likely to contribute to trends in the prevalence of T2DM, and thus the management of obesity may be important to reduce the prevalence of T2DM.
Identifiants
pubmed: 31275786
doi: 10.1007/s13340-018-0380-0
pii: 380
pmc: PMC6593010
doi:
Types de publication
Journal Article
Langues
eng
Pagination
198-205Déclaration de conflit d'intérêts
Conflict of interestThe authors declare that there is no conflict of interest associated with this manuscript.
Références
Ann Epidemiol. 1999 Nov;9(8):498-507
pubmed: 10549883
Diabetes Res Clin Pract. 2004 Dec;66(3):301-7
pubmed: 15609460
Lancet. 2007 Mar 3;369(9563):750-756
pubmed: 17336651
JAMA. 2007 Dec 12;298(22):2654-64
pubmed: 18073361
Diabetes Care. 2008 Oct;31(10):1991-6
pubmed: 18628569
Diabetes Care. 2009 Nov;32(11):2123-32
pubmed: 19875607
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
N Engl J Med. 2010 Mar 25;362(12):1090-101
pubmed: 20335585
Diabetes Care. 2010 Oct;33(10):2184-9
pubmed: 20639452
Diabetologia. 2012 Nov;55(11):2895-905
pubmed: 22890825
Diabetes Care. 2013 Jul;36(7):e95-6
pubmed: 23801818
Circulation. 2013 Sep 10;128(11):1198-205
pubmed: 23902756
J Diabetes Investig. 2012 Feb 20;3(1):39-40
pubmed: 24843544
J Diabetes Investig. 2014 Mar 23;5(2):162-9
pubmed: 24843756
J Epidemiol. 2014;24(6):460-8
pubmed: 24998950
Diabet Med. 2015 Oct;32(10):1319-28
pubmed: 25662570
Lancet Diabetes Endocrinol. 2015 Aug;3(8):624-37
pubmed: 26109024
JAMA. 2015 Sep 8;314(10):1021-9
pubmed: 26348752
Lancet. 2016 Apr 9;387(10027):1513-30
pubmed: 27061677
Diabet Med. 2016 Aug;33(8):1149-50
pubmed: 27429054
Diabetes Res Clin Pract. 2017 May;127:115-122
pubmed: 28365558
Diabetes Obes Metab. 2017 Nov;19(11):1537-1545
pubmed: 28387052
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596
pubmed: 28601585
JAMA. 2017 Jun 27;317(24):2515-2523
pubmed: 28655017
Clin Chem. 1972 Jun;18(6):509-15
pubmed: 5026763
Am Heart J. 1996 Apr;131(4):790-5
pubmed: 8721656
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693